دورية أكاديمية

Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

التفاصيل البيبلوغرافية
العنوان: Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
المؤلفون: Monk, Bradley J *, Toita, Takafumi, Wu, Xiaohua, Vázquez Limón, Juan C, Tarnawski, Rafal, Mandai, Masaki, Shapira-Frommer, Ronnie, Mahantshetty, Umesh, del Pilar Estevez-Diz, Maria, Zhou, Qi, Limaye, Sewanti, Godinez, Francisco J Ramirez, Oppermann Kussler, Christina, Varga, Szilvia, Valdiviezo, Natalia, Aoki, Daisuke, Leiva, Manuel, Lee, Jung-Yun, Sulay, Raymond, Kreynina, Yulia, Cheng, Wen-Fang, Rey, Felipe, Rong, Yi, Ke, Guihao, Wildsmith, Sophie, Lloyd, Andrew, Dry, Hannah, Tablante Nunes, Ana, Mayadev, Jyoti
المصدر: In The Lancet Oncology December 2023 24(12):1334-1348
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14702045
DOI:10.1016/S1470-2045(23)00479-5